Central 5-HTergic hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like pathophysiology
- J Transl Med. 2024 Jan 8;22(1):34. doi: 10.1186/s12967-023-04808-x.
- 1. Research Center for CFS/ME, Daejeon Hospital of Daejeon University, Daejeon, Republic of Korea.
- 2. Institute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.
- 3. Korean Medical College of Daejeon University, Daejeon, Republic of Korea.
- 4. College of Medicine, Kosin University, Busan, Republic of Korea.
- 5. Research Center for CFS/ME, Daejeon Hospital of Daejeon University, Daejeon, Republic of Korea. [email protected].
- 6. Institute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea. [email protected].
Objectives: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a significant medical challenge, with no indisputable pathophysiological mechanism identified to date.
Methods: Based on clinical clues, we hypothesized that 5-hydroxytryptamine (5-HT) hyperactivation is implicated in the pathogenic causes of ME/CFS and the associated symptoms. We experimentally evaluated this hypothesis in a series of mouse models.
Results: High-dose selective serotonin reuptake inhibitor (SSRI) treatment induced intra- and extracellular serotonin spillover in the dorsal raphe nuclei of mice. This condition resulted in severe fatigue (rota-rod, fatigue rotating wheel and home-cage activity tests) and ME/CFS-associated symptoms (nest building, plantar and open field test), along with dysfunction in the hypothalamic-pituitary-adrenal (HPA) axis response to exercise challenge. These ME/CFS-like features induced by excess serotonin were additionally verified using both a 5-HT synthesis inhibitor and viral vector for Htr1a (5-HT1A receptor) gene knockdown.
Conclusions: Our findings support the involvement of 5-HTergic hyperactivity in the pathophysiology of ME/CFS. This ME/CFS-mimicking animal model would be useful for understanding ME/CFS biology and its therapeutic approaches.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease